Future Pak LLC
Wixom, MI, United States
Due-diligence reportFind an accredited testing lab and confirm its scope covers your product and methods.
Future Pak LLC is a dietary supplement manufacturer in Wixom, MI, United States, certified to NSF/ANSI 455-2 and NSF/ANSI 455-4 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, softgels and tablets.
- Website
- futurepak.com
- Phone
- 248-486-0045
- Facilities listed
- 1
- Last checked
Dosage forms
As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.
Certified facilities
Manufacturing (1)
28115 Lakeview Drive, Wixom, MI 48393, United States
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Packaging/Labeling Operation - Primary Packaging
- Packaging/Labeling Operation - Secondary Packaging
- Warehousing
How Future Pak LLC compares
Among the 769 manufacturers we list, as of our last check.
- One of 8 capsule manufacturers we list in Michigan, and 325 in the United States. All capsule manufacturers in the USA · All in Michigan
- One of 8 tablet manufacturers we list in Michigan, and 228 in the United States. All tablet manufacturers in the USA · All in Michigan
- One of 3 softgel manufacturers we list in Michigan, and 160 in the United States. All softgel manufacturers in the USA
FDA recall records
No food or dietary supplement recall found under the name Future Pak LLC in FDA’s enforcement reports, as of .
We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check
FDA inspections
FDA lists 12 food or dietary supplement inspections at facilities matching Future Pak LLC, from 2010 to 2025, as of . 6 found no objectionable conditions and 6 found conditions the firm was left to correct.
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wixom, Michigan
3 citations posted:
- Hygienic practices (21 CFR 111.10(b))
- Hand-washing facilities (21 CFR 111.15(i))
- Equipment - controls, intended use (21 CFR 111.30(e))
Full citation text
Hygienic practices (21 CFR 111.10(b))
Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.
Hand-washing facilities (21 CFR 111.15(i))
Your hand-washing facilities are not adequate and are not convenient.
Equipment - controls, intended use (21 CFR 111.30(e))
You did not establish appropriate controls to ensure that your automated, mechanical, or electronic equipment functions in accordance with its intended use.
FEI 3013689974
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wixom, Michigan
8 citations posted:
- Specifications - components (21 CFR 111.70(b))
- Specifications - labels, packaging (21 CFR 111.70(d))
- Specifications - product received for packaging, labeling (21 CFR 111.70(f))
- Specifications - finished packaging, labeling (21 CFR 111.70(g))
See all 8 citations
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications and limits on contamination to ensure the quality of the dietary supplement.
Specifications - labels, packaging (21 CFR 111.70(d))
You did not establish label and packaging specifications.
Specifications - product received for packaging, labeling (21 CFR 111.70(f))
You did not establish specifications to assure that the product you received for packaging or labeling as a dietary supplement is adequately identified and is consistent with your purchase order.
Specifications - finished packaging, labeling (21 CFR 111.70(g))
You did not establish specifications for the packaging and labeling of the finished dietary supplement.
Quality control operations - specifications; components, packaging, labels (21 CFR 111.120(b))
Your quality control operations did not include determining whether components conform to established specifications.
Quality control operations - finished batch, specifications (21 CFR 111.123(a)(7))
Your quality control operations did not include determining whether each finished batch conforms to established product specifications.
Master manufacturing record - record requirements (21 CFR 111.210)
Your master manufacturing record did not include all required information.
Batch record - required information (21 CFR 111.260)
Your batch production record did not include all required information.
FEI 1824909
No action indicated · No objectionable conditions found
Inspected
Wixom, Michigan
FEI 3016408869
No action indicated · No objectionable conditions found
Inspected
Wixom, Michigan
FEI 3016408869
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wixom, Michigan
FEI 3013689974
Show all 12 inspections
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wixom, Michigan
3 citations posted:
- Hygienic practices (21 CFR 111.10(b))
- Hand-washing facilities (21 CFR 111.15(i))
- Equipment - controls, intended use (21 CFR 111.30(e))
Full citation text
Hygienic practices (21 CFR 111.10(b))
Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.
Hand-washing facilities (21 CFR 111.15(i))
Your hand-washing facilities are not adequate and are not convenient.
Equipment - controls, intended use (21 CFR 111.30(e))
You did not establish appropriate controls to ensure that your automated, mechanical, or electronic equipment functions in accordance with its intended use.
FEI 3013689974
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wixom, Michigan
8 citations posted:
- Specifications - components (21 CFR 111.70(b))
- Specifications - labels, packaging (21 CFR 111.70(d))
- Specifications - product received for packaging, labeling (21 CFR 111.70(f))
- Specifications - finished packaging, labeling (21 CFR 111.70(g))
See all 8 citations
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications and limits on contamination to ensure the quality of the dietary supplement.
Specifications - labels, packaging (21 CFR 111.70(d))
You did not establish label and packaging specifications.
Specifications - product received for packaging, labeling (21 CFR 111.70(f))
You did not establish specifications to assure that the product you received for packaging or labeling as a dietary supplement is adequately identified and is consistent with your purchase order.
Specifications - finished packaging, labeling (21 CFR 111.70(g))
You did not establish specifications for the packaging and labeling of the finished dietary supplement.
Quality control operations - specifications; components, packaging, labels (21 CFR 111.120(b))
Your quality control operations did not include determining whether components conform to established specifications.
Quality control operations - finished batch, specifications (21 CFR 111.123(a)(7))
Your quality control operations did not include determining whether each finished batch conforms to established product specifications.
Master manufacturing record - record requirements (21 CFR 111.210)
Your master manufacturing record did not include all required information.
Batch record - required information (21 CFR 111.260)
Your batch production record did not include all required information.
FEI 1824909
No action indicated · No objectionable conditions found
Inspected
Wixom, Michigan
FEI 3016408869
No action indicated · No objectionable conditions found
Inspected
Wixom, Michigan
FEI 3016408869
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wixom, Michigan
FEI 3013689974
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wixom, Michigan
FEI 1824909
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wixom, Michigan
1 citation posted:
- Specifications met - test, examinations; compliance (21 CFR 111.75(c)(2))
Full citation text
Specifications met - test, examinations; compliance (21 CFR 111.75(c)(2))
You did not conduct appropriate tests or examinations to determine compliance with the specifications established for strength.
FEI 3013689974
No action indicated · No objectionable conditions found
Inspected
Wixom, Michigan
FEI 1824909
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wixom, Michigan
5 citations posted:
- Master manufacturing record-specifications; packaged, label (21 CFR 111.205(b)(1))
- Procedures not in writing, fully followed (21 CFR 211.22(d))
- Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
- Review of representative number of batches (21 CFR 211.180(e)(1))
See all 5 citations
Master manufacturing record-specifications; packaged, label (21 CFR 111.205(b)(1))
Your master manufacturing record did not identify specifications for the points, steps, or stages in the manufacturing process where control is necessary to ensure that the dietary supplement is packaged and labeled as specified in the master manufacturing record.
Procedures not in writing, fully followed (21 CFR 211.22(d))
The responsibilities and procedures applicable to the quality control unit are not fully followed.
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Equipment and utensils are not cleaned at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.
Review of representative number of batches (21 CFR 211.180(e)(1))
Written procedures are not established for evaluations conducted at least annually to review records associated with a representative number of batches, whether approved or rejected.
Written record of investigation incomplete (21 CFR 211.192)
Written records of investigations into unexplained discrepancies and the failure of a batch or any of its components to meet specifications do not always include the conclusions and follow-up.
FEI 1824909
No action indicated · No objectionable conditions found
Inspected
Wixom, Michigan
2 citations posted:
- Habits of good sanitation & health (21 CFR 211.28(b))
- Annual visual exams of drug products (21 CFR 211.170(b))
Full citation text
Habits of good sanitation & health (21 CFR 211.28(b))
Production personnel were not practicing good sanitation and health habits.
Annual visual exams of drug products (21 CFR 211.170(b))
Reserve samples from representative sample lots or batches of drug products selected by acceptable statistical procedures are not examined visually at least once a year for evidence of deterioration.
FEI 1824909
No action indicated · No objectionable conditions found
Inspected
Wixom, Michigan
2 citations posted:
- In-process and laboratory control results (21 CFR 211.188(b)(5))
- Extent of discrepancy, failure investigations (21 CFR 211.192)
Full citation text
In-process and laboratory control results (21 CFR 211.188(b)(5))
Batch production and control records do not include in-process results for each batch of drug product produced.
Extent of discrepancy, failure investigations (21 CFR 211.192)
Investigations of an unexplained discrepancy did not extend to other batches of the same drug product.
FEI 1824909
No action indicated · No objectionable conditions found
Inspected
Wixom, Michigan
FEI 1824909
We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check
What Future Pak LLC says it offers
From Future Pak LLC’s own website, checked . Not verified by us.
Services
Packaging & bottlingShow quoteHide quote“We offer a full range bottle designs, including small-count, purse-sized vials with full disclosure wrap around labels.”
“We offer a full range bottle designs, including small-count, purse-sized vials with full disclosure wrap around labels.”
Source page · seen on
Stick packs & sachetsShow quoteHide quote“We offer a wide variety of capabilities that allow us to deliver customized stick pack solutions for multiple applications.”
“We offer a wide variety of capabilities that allow us to deliver customized stick pack solutions for multiple applications.”
Source page · seen on
We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims
What we checked, and what we didn’t
Confirmed from NSF’s public listing
Last checked
- NSF/ANSI 455-2 GMP certification
- NSF/ANSI 455-4 GMP certification
- 1 facility address
- Dosage forms in the certified scope
- Operations listed for each facility
Not verified by us
- Minimum order quantity (MOQ): the smallest order they accept
- Lead times and current capacity
- Prices
- Other certifications, like organic, kosher, halal or NSF Certified for Sport
- Whether they’re taking new clients
- Conditions inside the facility. We don’t visit or audit facilities.
- What the company’s own website says it makes and offers, shown above with quotes
Ask about these in your quote request. How we verify
Other capsule manufacturers in the United States
NSF lists 5 capsule facilities, including one in Tempe, AZ
Tempe, AZ, United States21stcenturyvitamins.com
- Capsules
- Gummies
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Centennial, CO
Centennial, CO, United States5280smc.com
- Capsules
Operations:- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Garden Grove, CA
Garden Grove, CA, United Statespackaging.com
- Capsules
- Gummies
- Powders
- Softgels
- Tablets
NSF/ANSI 455-2checked Nov 19, 2026Access Business Group, LLC
USDA OrganicNSF lists a capsule facility in Ada, MI
Ada, MI, United Statesamway.com
- Capsules
- Powders
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026NSF lists 2 capsule facilities, including one in Chandler, AZ
Gilbert, AZ, United Statesadeptlifesciences.com
- Capsules
- Liquids
- Powders
- Tablets
Operations:- Liquid formulation
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026ADH Health Products, Inc.
USDA OrganicNSF lists a capsule facility in Congers, NY
Congers, NY, United Statesadhhealth.com
- Capsules
- Oils
- Powders
- Tablets
Operations:- Coating
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026